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Both unilateral and bilateral ung volume reduction procedures are being 
advocated for treatment of severe, generalized emphysema. We analyzed the 
results of 166 consecutive patients who underwent unilateral (n = 87) or 
bilateral (n = 79) thoracoscopic stapled lung volume reductions to help define 
the role for these procedures. There was no statistically significant difference in 
the operative mortality (3.5% vs 2.5%), mean length of stay (11.4 - 1 vs 10.9 +- 
1 days), or morbidity for the unilateral and bilateral groups, respectively (p not 
significant for all variables). Oxygen dependence was eliminated in 18 (36%) of 
50 patients who had unilateral procedures and 30 (68%) of 44 of those who had 
bilateral procedures (p < 0.01). Prednisone was eliminated for 38 (54%) of 51 
unilateral-procedure patients, compared with 30 (85%) of 35 bilateral-proce- 
dure patients (p = 0.02). Overall, bilateral procedures produced a mean 
improvement in the forced expiratory volume in 1 second (FEV1) of 57%, 
compared with 31% for unilateral reduction procedures (p < 0.01). Our 
bilateral staple procedure produced a 72.8% mean increase in the FEV1 for 
patients who had upper lobe emphysema. Especially compromised patients 
(age _>75, with preoperative room air Po2 <50 mm Hg or FEV 1 <500 ml) had 
the same morbidity and operative mortality with unilateral or bilateral 
procedures, but they had a higher 1-year mortality (17% vs 5%), primarily 
because of respiratory failure after the unilateral operation (p < .001). 
Although unilateral staple lung volume reduction may produce an excellent 
result in a given patient, the bilateral procedure appears to be the procedure 
of choice, because itprovides better overall results at no increased morbidity or 
mortality compared with the unilateral procedure. The results of bilateral 
staple lung volume reduction by thoracoscopy appear to be comparable to 
those of median sternotomy. (J Thorac Cardiovasc Surg 1996;112:1331-9) 
L ung volume reduction surgery (LVRS) for treat- ment of emphysema is being performed with 
lasers or staples as unilateral or bilateral proce- 
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dures. 1-4 In a randomized, prospective study, we 
showed that unilateral thoracoscopic staple LVRS 
produced significantly greater eduction in supple- 
mental oxygen requirements, greater steroid inde- 
pendence, improved quality of life, and objective 
pulmonary function tests than contact-tip neody- 
nium:yttrium-aluminum-garnet las rtreatments) 
The free beam laser may be more effective than 
the contact-tip laser. Little 1 showed a greater im- 
provement with the free beam than our results with 
the contact ip 3 (18% vs 13%). With the combina- 
tion of staples and free beam laser treatment by 
means of unilateral thoracoscopy, Eugene reported 
results similar to those in our study using staples 
alone) There was no apparent benefit to the addi- 
tion of the laser to the staple procedure. Cooper 4' 5 
reported much greater improvement with a bilateral 
staple procedure (82%) compared with these results 
with unilateral procedures. 1-3 
On the basis of the results of previous tudies, we 
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Table I. Baseline characteristics 
All B i la tera l ly  Unilaterally 
Characteristic patients* treated patients* treated patients/ 
Number  166 79 87 
Age 67.8 _+ 0.54 67.7 _+ 0.66 67.9 _+ 0.84 
FVC 2.07 _+ 0.06 2.05 _+ 0.08 2.09 _+ 0.08 
FEV~ 0.67 + 0.02 0.65 -- 0.03 0.69 + 0.03 
FVC (%) 53.4 _+ 1.12 54.3 _+ 1.6 52.5 + 1.6 
FEVt  (%) 25.5 _+ 0.7 25 _+ 0.92 25.9 -- 1.1 
RV 4.7 _+ 0.11 4.7 _+ 0.18 4.8 _+ 0.13 
TLC 7.39 +_ 0.13 7.26 _+ 0.21 7.52 _+ 0.16 
RAW 5.4 + 0.21 6.15 _+ 0.37 4.87 + 0.23 
RV/TLC 0.69 _+ 0.01 0.69 _+ 0.01 0.69 + 0.01 
DLCO 5.12 _+ 0.24 5.4 _+ 0.32 4.8 _+ 0.35 
Po e 62.5 _+ 1.02 64 _+ 2.4 60.3 _+ 2.4 
Pco 2 44.8 _+ 0.7 44.5 ÷ 0.9 45.2 _+ 1.08 
FVC, Forced vital capacity; FEV1, forced expiratory volume in 1 second; 
RV, residual volume; TLC, total lung capacity; RAW, airway resistance; 
DLCO, diffusing capacity for carbon monoxide. 
*The pulmonary function test results are plethysmographic. Values are 
expressed as the mean -+ SEM. None of thep values, which compare the 
baseline characteristics of unilaterally treated patients with those of the 
bilaterally treated patients, was significant. 
adopted the bilateral thoracoscopic staple LVRS as 
our standard operation. We have accrued approxi- 
mately equivalent numbers of patients in the bilat- 
eral treatment group as in our initial group of 
patients treated with unilateral thoracoscopic staple 
LVRS. 
Although overall improvement after bilateral 
LVRS appears superior to results after unilateral 
reduction, some unilaterally treated patients have 
had excellent clinical results. In this study we ana- 
lyze the results of consecutive patients who under- 
went unilateral or bilateral operations for the treat- 
ment of generalized emphysema to compare the 
overall efficacy of these two approaches, to attempt 
to identify patients who respond well to unilateral 
procedures, and to help clarify the role for each 
approach. 
Patients and methods 
Between June 1994 and June 1995, 166 patients 67 -+ 7 
years old (mean _+ SD) underwent unilateral (n = 87) or 
bilateral (n = 79) staple LVRS. Entry criteria for this 
series have been previously described. 3 Despite maximal 
medical management, all patients had marked symptoms, 
as measured by a dyspnea index and quality-of-life assess- 
ment. Chest roentgenograms showed hyperexpansion f
the thorax, with flattening or inversion of the diaphragms. 
To be accepted for the procedure, the pattern of 
emphysema seen on computed tomography (CT) had to 
as severe. The CT scan be heterogeneous and graded 6 
pattern was classified as upper lobe if the emphysema was 
primarily in the upper lobes, lower lobe if concentrated in 
the lower lobes, and diffuse if there was a heterogeneous 
pattern of emphysema with discreet areas of severe em- 
physema in the upper and lower lobes. Radionuclide lung 
perfusion scans were also used to confirm the heteroge- 
neous pattern of emphysema. 
Contraindications to surgery included current cigarette 
smoking, age greater than 80 years, severe CO2 retention 
(Paco 2 >55 mm Hg), severe heart disease, history of 
cancer within the last 5 years, ventilator dependency, 
presence of a lung mass, or prior thoracic operation. All 
patients who underwent LVRS for treatment of emphy- 
sema were included in this study unless they had previ- 
ously undergone an operation for emphysema, if they 
underwent a laser operation as part of a previous tudy, or 
if a lung cancer was identified. 
Baseline function. Baseline characteristics of the two 
patient groups appear in Table I. All of the patients had 
severe fixed airflow limitation. The mean forced vital 
capacity was 2.07 L (54 _+ 9% predicted [mean _+ SD]) 
and the mean forced expiratory volume in 1 second 
(FEV1) was 0.67 (25.5% + 7% of predicted). The average 
result for the preoperative 6-minute walk was 350 feet. 
There were no statistically significant differences be- 
tween the two groups with respect to age, sex, lung 
function, Pao2, Paco2, CT emphysema score, smoking, or 
need for daily oxygen usage (defined as Pao2 <55 mm Hg 
at rest or exercise). Fifty-one patients (60%) in the 
unilateral-procedure group and 35 patients (45%) in the 
bilateral-procedure group were steroid dependent at the 
time of surgery (p not significant at baseline). Oxygen 
dependency was present in 50 (59%) of the unilateral- 
procedure group and 44 (56%) of the bilateral-procedure 
group Co not significant). There was a trend (not statisti- 
cally significant) toward a higher baseline FEV1 in pa- 
tients treated with unilateral LVRS. No patient had been 
accepted for lung transplantation, and one patient had a 
homozygous cq-antitrypsin deficiency. 
Assignment o the unilateral- or bilateral-procedure 
group was essentially sequential, with unilateral proce- 
dures being performed in the first half of the study group 
and bilateral procedures in the second half. After the 
bilateral phase of the study had started, 10 patients 
underwent unilateral operations. In eight patients, a het- 
erogeneous pattern of emphysema was found on the 
operated side, but the contralateral side showed a homog- 
enous pattern. Bilateral operations had been planned for 
two additional patients, but large air leaks developed 
while surgeons were operating on the first side. These 
patients had histories of prolonged steroid use, and oper- 
ating on their very soft lungs led to massive air leaks. 
When all efforts to seal the leaks were unsuccessful, the 
procedures were terminated without LVRS on the con- 
tralateral side. 
Pulmonary rehabilitation. Pulmonary rehabilitation is
an integral part of the treatment for all our patients who 
undergo LVRS. Many of the patients lived great distances 
from our medical center and did not have adequate 
rehabilitation programs at their local hospitals. Rehabili- 
tation, therefore, was not routinely performed preopera- 
tively. However, all patients began rehabilitation in the 
hospital after the operation. The rehabilitation program 
included education about proper breathing techniques, 
anxiety control, muscle stretching and strengthening exer- 
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cises, and walking on stairs and treadmills. This was 
continued on an outpatient basis at Chapman Medical 
Center for 2 to 3 weeks after discharge from the hospital. 
Patients were strongly encouraged to join a local rehabil- 
itation program after completion of the postoperative 
rehabilitation program at Chapman Medical Center. 
Operative techniques. All patients underwent unilat- 
eral or bilateral video-assisted thoracic surgery while 
under paralyzed (pipecuronium) general anesthesia 
(isoflurane) using a left-sided ouble-lumen tube (Mallin- 
crodt Anesthesia, St. Louis, Mo.). All procedures were 
performed, with patients in the lateral decubitus position, 
by one surgical group (R. M., R. F.). The trocar and 
thoracoscope were placed through the tenth intercostal 
space in the posterior axillary line. Three additional i to 2 
cm incisions were made for the endoscopic stapler and for 
standard, nonthoracoscopic instruments, such as a ring 
forceps. For bilateral procedures, patients were turned to 
the contralateral decubitus position for a separate skin 
preparation after completion of surgery on the initial side. 
The preoperative lung CT scan and ventilation/perfu- 
sion scan were used to identify areas of severely emphy- 
sematous lung targeted for resection. Ring forceps manip- 
ulated the lung into a 60 mm endoscopic stapler (ELC 60, 
Ethicon, Cincinati, Ohio) with bovine pericardium 4'5 
(Peristrips, Biovascular, Saint Paul, Minn.) or Instat 
(Johnson and Johnson, New Brunswick, N.J.) to buttress 
the staples. The staples were fired an average of 15 times 
for a bilateral operation. Typically, approximately one half 
of the upper lobe was resected. Specimen weights ranged 
from 30 to 114 gm (74 _+ 35 gm). Pleurodesis was not 
performed in any patient. The chest was drained with two 
apically placed chest tubes after completion of the proce- 
dure. Our policy is to not use suction on the chest 
drainage system unless the patient's condition is clinically 
unstable. Heimlich valves are used for prolonged air leaks 
(>5 days) to facilitate arlier discharge from the hospital. 7
After extubation in the operating room, patients were 
routinely transferred to the intensive care unit for over- 
night observation. 
Lung function studies. All patients underwent arterial 
blood gases and lung function studies on room air that 
included static lung volumes measured by plethysmo- 
graphic techniques, 8 timed spirometry, and single-breath 
diffusing capacity in accordance with American Thoracic 
Society recommendations, 9' lo and the values were com- 
pared with predictions. 11-13 All patients were considered 
to have fixed airflow limitation because the FEV~ after 
three inhalations of aerosolized albuterol (670 /xg) im- 
proved <12% or <200 ml. 1° Maximum inspiratory and 
expiratory flow volume curves, thoracic gas volume, 8and 
airway resistance 8 were measured in a plethysmograph 
(Models 2800 an d 6200, Sensormedics Inc., Yorba Buena, 
Calif.) and compared with predicted values. ~4 The recip- 
rocal of airway resistance, s conductance, was divided by 
the thoracic gas volume at which it was measured to 
calculate specific conductance. Residual volume was cal- 
culated by subtracting vital capacity from total lung ca- 
pacity. Complete plethysmographic lung function and 
elastic recoil studies were obtained before operation. 
Because follow-up information usually was obtained from 
the patients' local pulmonologists, only timed spirometry 
and arterial blood gas data were available after operation. 
Objective outcome assessment end points. Change in 
postbronchodilator FEV 1 and the percent change in 
FEV 1 were the primary continuous objective nd points 
measured to assess response to surgery. 
Relief from prednisone dependence and elimination of 
need for supplemental oxygen were assessed as noncon- 
tinuous variables. Physicians involved in the surgical pro- 
cedure did not make any recommendations or decisions 
regarding prednisone or oxygen treatment for any of the 
patients. These decisions were made independently b the 
patients' primary physicians. 
Dyspnea improvement was defined as ->2 point de- 
crease in the dyspnea index or final dyspnea score -<2. 
Lifestyle was assessed by the Medical Outcome Survey 
Short Form-36 (MOS SF-36) item quality-of-life ques- 
tionnaire, is
Mortality assessment. Operative mortality was defined 
as death occurring within 30 days of the procedure, before 
discharge from the acute care hospital, or in a rehabilita- 
tion facility if the patient was transferred there from the 
acute care hospital. One-year mortality was defined as 
death from any cause up to 1 year after surgery, and it 
included operative mortality. The clinical status of all 
patients was known. 
Statistical methods. Group descriptive statistics are 
expressed as the mean _+ standard error of the mean 
unless otherwise specified. Differences between groups 
are compared with two-tailed paired Student's t tests, with 
p < 0.05 considered significant. Pearson's )(2 statistics 
were used to analyze clinical features in the unilateral or 
bilateral staple groups. 16 
Clinical evaluation. Before operation and 6 months 
after operation, the MOS 36-item quality-of-life question- 
naires 15 and the Modified Medical Research Council 
(MMRC) dyspnea index 17 were scored to document life- 
style improvement and response to operative intervention. 
Patients were referred to their local pulmonologists for 
weaning pulmonary medicines and oxygen, as appropriate. 
We contacted the patients to determine their clinical 
status and their use of pulmonary medicines and oxygen. 
Results 
This study included 166 consecutive patients who 
underwent LVRS. Follow-up pulmonary function 
evaluations were available for 139 (87%) of 161 
surviving patients. Despite repeated efforts to ques- 
tion the other patients, no follow-up pulmonary 
functions could be obtained, even for patients who 
were clinically doing well. One-year clinical fol- 
low-up and mortality data were available for all 
patients. 
Mortality. The three deaths (3.5% mortality) for 
the unilateral procedure resulted from respiratory 
failure (1 patient), contralateral tension pneumo- 
thorax (1), and a cardiac event (1). The two deaths 
(2.5% mortality) after the bilateral operation re- 
sulted from an acute abdomen (1) and respiratory 
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Table II. Mortality after lung volume reduction 
surgery for emphysema 
Acute Mortality 1-Year Mortality 
Patients No. % No. % 
All patients* 
Unilaterally treated 3/87 3.4 15/87 30,4 
Bilaterally treated 2/79 2,5 2/79 2.5 
Hypoxemic patients? 
Unilaterally treated 0/23 0 7/23 30.04 
Bilaterally treated 1/12 8.3 1/12 8.3 
*p < 0.01 for the compared groups. 
?p < 0.001 for the compared groups. 
Table III. Complications of lung volume reduction 
surgery for emphysema 
Morbidity 
All patients Unilaterally treated Bilaterally treated 
(%) patients (%) patients (%) 
Air leak (>7 days) 50 53 47 
Bleeding 1 0 1 
Reoperation 5 5 5 
Pneumonia 3.5 4 3 
Acute abdomen 0.7 0 1 
failure (1). There was no statistically significant 
difference in the mortality for the two groups, and 
there were no additional deaths at 3 months of 
follow-up (Table II). 
Morbidity. Morbidity for the two procedures i
summarized in Table III. The mean postoperative 
length of stay was 11.4 _+ 1.1 days and 10.9 _+ 1.1 
days for the unilateral and bilateral treatment 
groups, respectively (pnot significant). 
Reoperation for closure of a persistent air leak 
was performed in four patients (5 % ) in the unilat- 
eral-treated group and four patients (2% Of the 
lungs at risk) in the bilaterally treated group. The 
use of the Heimlich valve, as previously reported, 7 
has essentially eliminated the need for reoperation 
for air leak. The use of the Heimlich valve began 
during the bilateral phase of the study. After a 
bilateral Operation, 14 (18%) patients were dis- 
charged with Heimlich valves for an average of 6.5 
days. The remaining patients had their chest tubes 
removed while in the hospital. 
Discharge was to a rehabilitation hospital for 18 
(23%) of the bilateral-procedure patients and 17 
(19%) of the unilateral-procedure patients. At the 
Table IV. Comparison of the outcomes for 
unilateral or bilateral thoracoscopic staple lung 
volume reduction surgery in patients with a 
heterogenous pattern of emphysema 
Unilaterally treated Bilaterally treated 
Outcome patients patients 
Steroid independence 38/41 (54%) 30/35 (85%) 
Oxygen independence 18/50 (36%) 30/44 (68%) 
Postop. dyspnea 44% 12% 
grade 3 or 4 
time of transfer, two of these patients' lungs were 
being ventilated, but they were subsequently 
weaned. The remaining patients were transferred 
to the rehabilitation facilities for social reasons 
(i.e., they came from long distances to our facility 
and were without family or friends for support) or 
because their conditioning was poor preopera- 
tively. 
Steroid dependency. The use of oral steroids at 6 
months after the operation was recorded. In the 
unilateral-procedure group, 28 (54%) of the 51 
patients who were taking prednisone preoperatively 
no longer used prednisone. In the bilateral-proce- 
dure group, 30 (85%) of the 35 patients who were 
taking prednisone preoperatively nolonger equired 
prednisone (p = 0.02) (Table IV). 
Oxygen dependency. The use of oxygen at 6 
months after the procedure was recorded. In the 
unilaterally treated group, 18 (36%) of the 50 
patients who were oxygen dependent preoperatively 
did not use any supplemental oxygen postopera- 
tively. In the bilaterally treated group, 30 (68%) of 
the 44 patients who were oxygen dependent preop- 
eratively were completely off oxygen postoperatively 
(p < 0.01). For patients with a preoperative room 
air Pao 2 ---50 mm Hg, the chance of oxygen inde- 
pendence after a unilateral or bilateral operation 
was much less (12% and 35%, respectively). 
Dyspnea scale. After both types of procedures, 
some patients still had significant dyspnea. In the 
unilaterally treated group, 73% of the patients had 
grade 3 or 4 dyspnea preoperatively, and 44% of the 
patients had dyspnea postoperatively. Although 
76% of bilateral-treatment pa ients had grade 3 or 4 
dyspnea preoperatively, only 12% had dyspnea fter 
operation (p < 0.001). 
Pulmonary function: follow-up. There was no 
difference in pulmonary function results at initial 
follow-up visits (average 80 _+ 6 days) compared 
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Table V. Response to lung volume reduction surgery 
All patients Unilaterally treated patients Bilaterally treated patients 
Characteristic Preop Postop p Value Preop Postop p Value Preop Postop p Value 
FEV 1 0.68 0.94 <0.0001 0.73 0.94 <0.01 0.64 0.97 <0.0001 
FEV 1 (%) 25.8 35.7 <0.0001 27 33 <0.01 24.6 38 <0.0001 
FVC 2.1 2.3 <0.01 2.18 2.37 00.16 2.04 2.28 <0.05 
FVC (%) 53 60 <0.001 54 58 00.06 53.7 60 <0.001 
Prednisone 4.5 0.5 <0.0001 4.8 0.7 <0.001 4.2 0.35 <0.0001 
02 (L) 1.1 0.3 <0.0001 1.09 0.46 <0.002 1.17 0.32 <0.0001 
Dyspnea 2.9 1.9 <0.0001 2.89 2.14 <0.001 2.9 1.8 <0.0001 
FEVj, Forced expiratory volume in 1 second; FVC, forced vital capacity; 0 2 (g), oxygen use in liters; Preop, preoperative alues; Postop, postoperative alues. 
Table VI. Effect of follow-up time on outcome 
Uni;ateral procedure Bilateral procedure 
Percent change Percent change 
Interval Change in FEV 1 from baseline Change in FEV 1 from baseline 
Baseline 0.74 _+ 0.03 0.63 _+ 0.03 
0-3 Months 0.94 _+ 0.07* 27 0.97 ± 0.03* 55 
3-12 Months 0.97 ± 0.05* 31 0.98 ± 0.03* 57 
FEV1, Forced expiratory volume in 1 second. 
*p < 0.001. 
with subsequent 6-month follow-up at 163 _+ 10 days 
(Table V). Results of unilateral and bilateral volume 
reduction procedures are summarized in Tables IV, 
V, and VI. The mean improvement in the FEV 1 
from baseline for the unilateral and bilateral oper- 
ations were 31% and 57%, respectively. Patients 
with predominantly upper lobe disease had signifi- 
cantly greater improvement in pulmonary function 
after unilateral or bilateral reduction than patients 
with diffuse or lower lobe disease (p < 0.01). For 
unilateral procedures, upper lobe disease was asso- 
ciated with a 35% _+ 5% improvement from base- 
line, lower lobe disease with a 26% + 7% improve- 
ment, and diffuse disease with a 15.7% _+ 7% 
improvement. For bilateral procedures, the im- 
provement from baseline was 68% _+ 8%, 47.1% _+ 
18%, and 36.8% _+ 9% for upper, lower, and diffuse 
disease, respectively (Fig. 1). 
Bilateral procedures in hyperinflated patients. 
In 41 patients with a diapragmatic excursion <3 
cm, hyperinflation (total lung capacity [TLC] 
>120% predicted; mean TLC 130% _+ 1.48%) 
and predominantly upper lobe disease, bilateral 
thoracoscopic LVRS produced a 72% _+ 8% im- 
provement in FEV 1 from baseline (average 420 _+ 
50 ml increase). 
Patients responding well to unilateral surgery. 
Although the overall response was significantly greater 
for patients undergoing bilateral LVRS, some patients 
responded well to unilateral procedures. Multivariate 
analysis was performed to identify factors that could 
predict an excellent response to a unilateral proce- 
dure. No such factors could be identified. 
However, one subgroup of unilateral-procedure pa- 
tients had the same postoperative r sult as bilateral- 
procedure patients with the same features. Patients 
younger than 75 years initially seen with predomi- 
nantly upper lobe disease, hyperinflation (TLC >7.5 
L), normal Pco2 (<46 mm Hg), and preserved ia- 
phragmatic excursion on at least one side (>-2.0 cm) 
had a mean increase in FEV 1 of 340 ml (45% _+ 15%). 
Equivalent patients undergoing bilateral procedures 
showed amean increase in the FEV 1 of 46.6% _+ 9% 
(355 ml). This subgroup of patients also had a signif- 
icantly greater response to unilateral volume reduction 
compared with the rest of the unilaterally treated 
patients who experienced a mean increase in FEV 1 
22% _+ 5% of predicted increase in FEV1, 147 ml 
average increase (p < 0.02). 
Relationship between tissue resected and re- 
sponse. An average of 74 gm (___35.5 gm SD) of 
tissue was resected from patients. Unilateral proce- 
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Fig. 1. Disease location influences the response to treat- 
ment, as is demonstrated by the correlation between the 
postoperative change in the forced expiratory volume in 1 
second (FEV1) and the location of the most severe 
emphysema byunilateral nd bilateral lung volume reduc- 
tion surgery. Upper is upper lobe predominant. Lower is 
lower lobe predominant. Diffuse is areas of severe mphy- 
sema in all lobes. 
dures removed approximately one half as much 
tissue (46 + 16 gin) as bilateral procedures (98 _+ 28 
gm; p < 0.0001). Improvement in lung function 
(change in FEV1) after the procedure correlated 
with the total amount of lung tissue resected, as seen 
in Fig. 2 (r = 0.547; p < 0.0001). 
One-year mortality. The 1-year mortality (includ- 
ing the operative mortality and death after discharge 
from the hospital) was 17% (15 patients) for the 
unilateral group and 5.1% (4 patients) for the 
bilateral group (p < 0.01) (see Table VI). The 
primary cause of delayed mortality was respiratory 
failure that occurred when a unilateral operation 
failed to produce enough improvement. Clinical 
factors associated with this delayed mortality in the 
unilateral-procedure g oup were preoperative room 
air Po 2 <50 mm Hg, age >75 years, and FEV1 <500 
ml (p < 0.001). After a unilateral procedure, pa- 
tients with a preoperative room air Po 2 <50 mm Hg 
had a 30% 1-year mortality. 
Discussion 
The goals for LVRS for treating emphysematous 
pulmonary disease are to improve objective pulmo- 
nary function, reduce or eliminate supplemental 
oxygen or steroid dependence, and significantly im- 
prove subjective dyspnea, with aceeptible morbidity 
and mortality levels. Previous studies have shown 
that unilateral and bilateral procedures can achieve 
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Fig. 2. Effect of tissue resection on lung function is 
shown by the correlation between grams of lung tissue 
resected and postoperative change in the forced expira- 
tory volume in 1 second (FEV1). 
not, however, provide adequate data to compare the 
morbidity, mortality, and clinical outcomes after 
unilateral or bilateral operations, to determine rel- 
ative benefits, or to define the indications for each of 
these procedures. We analyzed the results of the 166 
patients treated with unilateral or bilateral thoraco- 
scopic LVRS at our institution to address these 
issues. 
A bilateral procedure is expected to produce 
greater overall improvement than a unilateral pro- 
cedure. In this study the bilateral procedure pro- 
vided greater oxygen independence (68% vs 35%), 
prednisone independence (86% vs 56%), and 
greater improvement in the FEV 1 than the unilat- 
eral procedure (p < 0.05). Grade 3 or 4 dyspnea still 
affected 44% of patients after a unilateral operation 
but affected only 12% after a bilateral operation 
(p < 0.001). Because some patients have symptoms 
even after a bilateral procedure, it appears to be the 
procedure of choice. 
Is there any role for the unilateral procedure? 
One potential rationale for a unilateral procedure is
that some patients may be too debilitated to tolerate 
a bilateral procedure, and a unilateral procedure 
may be safer and can be done to improve the patient 
sufficiently for operative intervention on the con- 
tralateral side. However, the results in this study 
argue against hat approach. Even for severely com- 
promised patients, the operative morbidity and mor- 
tality rates for unilateral and bilateral operations 
were the same, but the clinical outcome was much 
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better for the bilateral procedure. Severe debility is 
therefore not an indication for performing a unilat- 
eral operation rather than a bilateral operation. 
This study shows that the short-term and long- 
term results are better for severely debilitated pa- 
tients with a bilateral operation than with a unilat- 
eral procedure. Although operative mortality is the 
same for these two operative approaches, 1-year 
follow-up data reveal a dramatically higher mortality 
for the unilateral procedure compared with the 
bilateral LVRS. This delayed mortality affected 
severely debilitated patients (i.e., preoperative room 
air Po2 -<50 mm Hg, age >-75 years, or FEV1 -<500 
ml) who did not improve nough with the unilateral 
procedure to sustain survival. There was no delayed 
mortality in this subgroup of patients after bilateral 
operations. These data also show that an extremely 
low FEV 1 is not a contraindication to LVRS. The 
operative mortality was not increased for patients 
with an FEV~ <500 ml. This study suggests that a 
bilateral procedure is the procedure of choice for 
severely compromised patients. 
What rationale remains for a unilateral proce- 
dure? LVRS for emphysema is a procedure that 
provides palliation for uncertain durations. It is 
unknown whether a longer period of palliation will 
be achieved if a patient initially undergoes a bilat- 
eral operation or a unilateral operation with plans to 
reserve the contralateral side for a time when the 
patient again has symptoms. 
Laros 18 found that operation for giant bullae 
significantly improved all patients with severe dys- 
pnea for 2 to 5 years, but that all patients eventually 
returned to their preoperative l vel of dyspnea. 
Patients with LVRS for generalized emphysema 
may have similar durations of clinical benefit as 
patients who undergo operations for giant bullae. 
Long-term follow-up is needed to determine how 
the duration of clinical improvement with an initial 
bilateral operation compares with results from an 
initial unilateral operation with a plan to save treat- 
ing the contralateral side until the return of symp- 
toms. 
If the surgical plan is to perform sequential 
operations, it is necessary tobe able to predict which 
patients will get enough improvement from a uni- 
lateral operation. Because our multivariate analysis 
failed to identify such patients, our current opera- 
tive approach is a bilateral operation. 
A unilateral procedure may be the procedure of 
choice for hyperinflated patients (TLC >7.5 L) with 
Paco 2 <45 mm Hg and diaphragmatic excursion >2 
cm. These patients had the same improvement in
the FEV 1 whether the procedure was unilateral or 
bilateral. If these findings are confirmed in other 
studies, this may represent a subgroup of patients 
for unilateral LVRS. 
Our standard operation is a bilateral staple oper- 
ation, although we do perform unilateral operations 
in selected patients. Even during the bilateral LVRS 
phase of this study, unilateral operations were per- 
formed for eight patients who had a heterogeneous 
emphysema on one side and a homogenous pattern 
on the nonoperated side. Two additional patients 
had large air leaks that developed uring the oper- 
ation on the first side when a bilateral operation had 
been planned. These patients had lungs that were 
very soft, and the patients had a history of prolonged 
use of steroids. When all efforts to seal the leaks 
were unsuccessful, the procedures were terminated 
without LVRS on the contralateral side. Unilateral 
operations are also indicated for patients with con- 
traindications for an operation on the opposite side, 
such as prior thoracotomy, prior pleurodesis, or 
extensive pleural disease seen on roentgenograms. 
Bilateral staple LVRS can be performed by a 
VATS procedure, as in the current study, or through 
a median sternotomy, asdeveloped by Cooper. 4The 
average improvement in the FEV 1 is somewhat 
related to the degree of hyperinflation. Cooper's 
patients had an average TLC of 144%. We selected 
a subgroup of hyperinflated patients comparable to 
Cooper's patients. These 41 patients had an average 
improvement in the FEV 1 of 410 ml (72%), com- 
pared with the 82% improvement for Cooper's 
patients. The results of these studies suggest hat 
bilateral procedures can be performed by median 
sternotomy or bilateral thoracoscopy with approxi- 
mately equivalent responses. The incision is not as 
important as the procedure (i.e., laser or staples, 
unilateral or bilateral) to be performed. 
The optimal amount of lung to be resected isalso 
unknown. In this series, up to 114 gm of tissue was 
resected from one lung. Our current practice is to 
resect at least one half of the upper lobe from each 
lung, with an average weight of 60 to 75 gm per side. 
A correlation was seen between the total weight of 
tissue resected (including staples and bovine peri- 
cardium) and response to LVRS (see Fig. 2). This 
figure does not identify a point of diminishing 
returns beyond which further esection is associated 
with a lesser increase in postoperative FEV 1. Per- 
haps our resections should be even more extensive. 
Areas of severe emphysematous change can be 
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resected very aggressively because the Heimlich 
valve fascilitates closure of prolonged air leaks and 
resolution of postoperative apical air spaces without 
the need for reoperation or pleural tents ]  
This study suggests that the standard operation 
for a patient with severe heterogeneous emphysema 
should be a bilateral staple LVRS that is performed 
by median stenotomy or video-assisted thoracic sur- 
gery. Uni lateral  operations are reserved for patients 
with unilateral heterogeneous emphysema, prior 
contralateral thoracic operations, pleural scarring or 
pleurodesis, or a large air leak that cannot be closed 
while operating on the first side during a p lanned 
bilateral operation. 
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Discussion 
Dr. Claude Desehamps (Rochester, Minn.). Dr. Mc- 
Kenna and his group have demonstrated through a retro- 
spective study that volume reduction can be achieved 
through the scope, whether it is done on one or two sides, 
with reasonable results in this challenging roup of pa- 
tients. Dr. McKenna, you advertise "two sides for the 
price of one," and you say that treatment of the upper 
lobe disease has a better prognosis than for the middle or 
lower lung. I think it is difficult to draw any other 
conclusion from your study. 
Lung volume reduction surgery, as suggested by Joe 
Miller earlier this week, has really been a roller-coaster 
ride. For us mortals north of St. Louis, arguing the 
legitimacy of this procedure with our Medicare provider 
has been only one of the challenges. The quest for the 
ideal patient is never ending. The challenging postopera- 
tive care has been equalled by problems in rehabilitation, 
psychiatry, and cost-benefit issues. Although it has insuf- 
flated some badly needed fresh air in the lung mechanics' 
community, it sometimes gives the impression that the 
wheel is being reiuvented, especially when you look at the 
French-European experience; those researchers have 
been through this before, although perhaps in a less 
selective way. In our effort to choose our patients better, 
we do lung mechanics in all our patients with an esopha- 
geal balloon, and what we found is that when the maxi- 
mum flow is plotted against he transpulmonary pressure 
or elastic recoil, when we have a shift of the expected 
curve to the right, our patients did not do as well. We 
concluded that airway obstruction i those patients might 
result from causes other than emphysema alone. Those 
patients do not fare very well, and this understanding is 
now part of our selection process for lung volume reduc- 
tion patients. 
You correlated the amount of lung resected and the 
changes in FEV 1 and found a correlation of 0.5, which 
would explain only about 30% of the relationship between 
the amount resected and the increase in FEW 1. It seems 
that using the changes in total lung capacity or residual 
volume would have been a better physiologic predictor of 
postoperative r sults. Is there an upper limit in grams of 
tissue resected that you suggest to aim for, and has your 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 112, Number 5 
McKenna et al. 1 3 3 9 
technique of resection been consistent through that study 
period? 
Have you identified preoperative factors associated 
with a poor result for patients who did survive but did not 
do as well or for patients who got worse? 
You do not use rehabilitation before and only encour- 
age it after the operation, but you say that it is part of the 
treatment and part of the indication for patients who do 
not respond to maximal treatment. The article does not 
give a sense of whether ehabilitation is responsible for 
any improvement in your patient population. In those 
circumstances why use it at all, especially if in some places 
of the country it is not reimbursed? 
You have shown that thoracoscopy can achieve results 
comparable to sternotomy, especially for bilateral surgery. 
Considering that VATS is not cheaper and probably a 
longer procedure, why not use a sternotomy for everyone? 
Dr. McKenna. Your first question was about how much 
lung tissue to resect. We have resected as much as 112 gm 
on one side and 114 gm on the other side; we have done 
very aggressive resections. I don't know the optimal 
amount o resect. As you mentioned, the increase in the 
FEV 1 continues to climb with increasing amounts of 
resection. Generally, we aim to remove at least one half of 
the upper lobe on each side, and if these upper lobes are 
completely destroyed, we take out the entire upper lobes. 
For patients that have cq-antitrypsin deficiency, we per- 
form bilateral lower lobectomies. The technique has been 
consistent through the entire period. 
I think the most important preoperative factor is a 
heterogenous pattern of emphysema nd that it is very 
strongly heterogeneous if there is a big difference between 
the degree of anatomic destruction of lung tissue in one 
area compared with the better area that is to be left 
behind. Pulmonary rehabilitation has been very exten- 
sively studied. There are plenty of randomized, prospec- 
tive studies that show that pulmonary rehabilitation fails 
to improve pulmonary function and fails to even slow the 
decline in pulmonary function. I do not think there is any 
question that this operation, which dramatically improves 
pulmonary function, is much better treatment and should 
be covered by the Health Care Finance Administration 
(HCFA) and paid for by the third-party payers. I think 
that pulmonary rehabilitation does have some benefit for 
the patients in that it can get them in better shape 
preoperatively; it can cut down the need for some patients 
to be transferred to rehabilitation facilities postopera- 
tively. Outpatient rehabilitation is much less expensive 
than inpatient rehabilitation. I believe that is an important 
benefit. It also is helpful in excluding patients who are not 
good candidates--those who cannot complete the reha- 
bilitation or do not have the motivation to do the work 
that they need to do after the operation. 
You asked why I do VATS. I did 12 median sternoto- 
mies, and I have done the rest of our 350-case xperience 
with video-assisted surgery. I do not think that VATS is 
any more expensive than an open procedure. It routinely 
takes us 1 to 1.5 hours to get both sides done with two 
separate preparations and drapings. As you saw in the 
slide, we use a reusable trocar for the camera. We do not 
use any additional trocars; we do not use any disposable 
instruments. We use a stapler, which is also used for the 
open procedure. I find it technically easier to deal with 
adhesions that are located diffusely through the chest or 
especially posteriorly when I have a lateral approach 
rather than an anterior approach. Twenty-four percent of 
our patients have had at least one half of the pleural space 
obliterated by adhesions, and I find it technically easier to 
lyse those adhesions from the side than from the front. 
Dr. Akio Wakabayashi (Irvine, Calif.). A 17% mortality 
at 1 year after unilateral lung volume reduction is unbe- 
lievably high. In my own experience, 39 of 579 patients 
were dead i year after unilateral thoracoscopic treatment 
of emphysema. Of our 841 patients, only 23% required 
second-side operations, with a mean interval of 1 year. 
Last year, I operated on one patient who had had other 
side treated by laser bullectomy 6 years earlier, and this is 
the longest-living patient. I have 178 patients who had 
unilateral thoracoscopy laser pneumoplasty more than 3 
years ago and are doing still well. This illustrates the 
long-lasting beneficial effect of unilateral surgery. 
Regardless of the technique we use, the surgical treat- 
ment of emphysema is palliative in nature. This may be a 
philosophical question, but I still believe that the unilat- 
eral procedure is all we need to do for most patients, 
because they enjoy life after unilateral surgery. 
Dr. McKenna. We have experience following patients 
with unilateral and bilateral operations. Although some 
patients are dramatically better after unilateral proce- 
dures, a much higher percentage of our patients dramat- 
ically improve after bilateral operations. Overall, when 
you look at the improvement in the dyspnea scale, patients 
who have bilateral procedures average much greater 
improvement on the dyspnea scale. Although some pa- 
tients may improve and be happy with their results after 
unilateral procedures, with the bilateral procedure, a 
greater percentage of patients are improved, and the 
amount of improvement is greater. Our multivariate 
analysis failed to identify which patients improve enough 
with a unilateral procedure. We therefore recommend the 
bilateral procedure as the standard operation. 
